BCPC (Balchem) ROC (Joel Greenblatt) %: 47.25% (As of Mar. 2026) — 23% Above Median


BCPC Balchem Corp BCPC
94 GF Score
Price $171.20
GF Value $177.10
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Balchem ROC (Joel Greenblatt) %?

Balchem BCPC +1.27% 94 ROC (Joel Greenblatt) % is 47.25% as of Mar. 2026, which is 23% above its 10-year median of 38.42. GuruFocus rates BCPC with a GF Score™ of 94/100 and a GF Value™ of $177.10 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,607 Chemicals companies, Balchem ranks better than 94.03% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Balchem's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 47.25%.

The historical rank and industry rank for Balchem's ROC (Joel Greenblatt) % or its related term are showing as below:

BCPC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 33.89   Med: 38.42   Max: 49.21
Current: 45.8

During the past 13 years, Balchem's highest ROC (Joel Greenblatt) % was 49.21%. The lowest was 33.89%. And the median was 38.42%.

BCPC's ROC (Joel Greenblatt) % is ranked better than
94.03% of 1607 companies
in the Chemicals industry
Industry Median: 9.38 vs BCPC: 45.80

Balchem's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 6.70% per year.


Balchem  (NAS:BCPC) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Balchem ROC (Joel Greenblatt) % Related Terms


Balchem ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Balchem's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Balchem ROC (Joel Greenblatt) % Chart

Balchem Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.22 38.49 38.74 45.15 49.21

Balchem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.05 44.62 46.32 45.50 47.25

BCPC vs PRM, SXT, CBT: ROC (Joel Greenblatt) % Comparison

For the Specialty Chemicals subindustry, Balchem's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Balchem ROC (Joel Greenblatt) % vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Balchem's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Balchem's ROC (Joel Greenblatt) % falls into.


BCPC
94GF Score
Balchem Corp BCPC
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Balchem ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(143.596 + 131.449 + 15.999) - (144.669 + 0 + 27.896)
=118.479

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(154.232 + 146.743 + 15.093) - (136.191 + 0 + 12.698)
=167.179

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Balchem for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=218.94/( ( (322.84 + max(118.479, 0)) + (318.2 + max(167.179, 0)) )/ 2 )
=218.94/( ( 441.319 + 485.379 )/ 2 )
=218.94/463.349
=47.25 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 47.25% mean?
Balchem (BCPC) has a ROC (Joel Greenblatt) % of 47.25% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Balchem and its competitors. This is 23% above median its historical median of 38.42. Over the past decade, Balchem's ROC (Joel Greenblatt) % has ranged from 33.89 to 49.21. According to the industry distribution chart, Balchem ranks #96 out of 1607 companies in the Chemicals industry, placing it in the top 6%.
Is Balchem's ROC (Joel Greenblatt) % too high?
Balchem's current ROC (Joel Greenblatt) % of 47.25% is 23% above median its 10-year median of 38.42. Over the past 10 years, this metric has ranged from a low of 33.89 to a high of 49.21. The Chemicals industry median ROC (Joel Greenblatt) % is 9.38. Balchem's value of 47.25% is 403.7% above this industry median. Based on the distribution chart, Balchem ranks #96 out of 1607 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Balchem has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Balchem's ROC (Joel Greenblatt) % compare to PRM and SXT?
According to the Chemicals industry distribution chart, Balchem ranks #96 out of 1607 companies for ROC (Joel Greenblatt) %. This places Balchem in the top 6% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 9.38. Balchem's value of 47.25% is 403.7% above this benchmark. Historically, Balchem's own ROC (Joel Greenblatt) % has ranged from 33.89 to 49.21 over the past decade. While the company's 10-year median is 38.42 vs. the industry median of 9.38, Balchem has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Chemicals company?
The median ROC (Joel Greenblatt) % among Chemicals companies is 9.38, based on 1,607 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Balchem's current ROC (Joel Greenblatt) % of 47.25% is 403.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Balchem and its competitors. For the Chemicals industry, the median ROC (Joel Greenblatt) % is 9.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Balchem's current ROC (Joel Greenblatt) % is 47.25%, which is 23% above median its own 10-year median of 38.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balchem stock overvalued right now?
Based on GuruFocus' analysis, Balchem (BCPC) is currently considered Fairly Valued. The stock's GF Value™ is $177.10, compared to a current price of $171.20 — trading 3.3% below its estimated fair value. The current ROC (Joel Greenblatt) % is 47.25%, which is 23% above median its 10-year median of 38.42 and 403.7% above the Chemicals industry median of 9.38. Balchem's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Balchem (BCPC), the current ROC (Joel Greenblatt) % is 47.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Balchem (BCPC) Overvalued in 2026?

Based on GuruFocus' analysis, Balchem stock appears to be undervalued. The current stock price of $171.20 is trading 3.3% below its estimated GF Value™ of $177.10. GuruFocus considers Balchem to be Fairly Valued.

Key valuation signals for BCPC:

  • ROC (Joel Greenblatt) %: 47.25% (23% above median its 10-year median of 38.42)
  • GF Value™: $177.10 vs. price of $171.20 (3.3% below fair value)
  • GF Score™: 94/100 with 2 warning signs
  • Industry Position: 403.7% above the Chemicals median (#96 of 1607)

No single metric tells the full story. See the BCPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Balchem Business Description

Other Exchanges BL9B:Germany
Address 5 Paragon Drive, Montvale, NJ, USA, 07645
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
94GF Score

Get the complete analysis for BCPC

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$171.20
Price
$177.10
GF Value